Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by u2bobon May 09, 2018 12:29pm
101 Views
Post# 28005426

RE:Patent approved......

RE:Patent approved......
hotginger wrote: IDx, a privately-held AI diagnostics company, today announced its founder and president, Michael Abramoff, MD, PhD, has been awarded U.S. Patent No. 9,924,867 for a system that can automatically measure arterial and venous diameters in blood vessels, an important predictor of cardiovascular health.


Patent is fine ...shows we are on the right track ...I'm more interested in customers wanting to use our proven software .. Diagnos is able to do a few things too...from the NR Nov. 22nd below highlighted ...the statement from our client is the kind of thing you like to hear when building  a working relationship ...I am wondering who might be the one that wants to get Cardio testing going with DR  ?  ...We should be getting some updates soon it has also been more than 6 months Sept 19th when our C.M.O...mentioned launch of Cardio first half of 2018... 


"In an ever-changing healthcare environment, we do not only innovate with our current AI platform, but we also bring new applications to help doctors monitor closely the impact of medication on patients. The project will start this month, even though the Cardio application is not fully operational. Our customer believes that we are on track to deliver a new non-invasive test that will change the healthcare future for chronic diseases through the use of retina imaging." said Mr. Andr Larente, CEO of DIAGNOS.

I hope we long suffering shareholders get an update soooooooooooon !!!

Later ...
Bob


Bullboard Posts